PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer

Clinical trial NCT01899599 · COMPLETED

Trial details

NCT number: NCT01899599
Sponsor: Glycotope GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Epithelial Cancer Recurrent Fallopian Tube Cancer Primary Peritoneal Cancer

Start date: 2013-09-01
Primary completion: 2017-04-20
Enrollment: 216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.